K C Anderson

2.8k citations
20 papers · 2.0k indexed · 1 hit paper · h-index 16
Topics
Multiple Myeloma Research and Treatments (12 papers)Protein Degradation and Inhibitors (8 papers)Ubiquitin and proteasome pathways (5 papers)

In The Last Decade

K C Anderson

20 papers receiving 1.9k citations

Hit Papers

The proteasome inhibitor PS-341 inhibits growth, induces ...200120262009201720014008001.2k

Peers

K C Anderson
Comparison fields: 5 of 88
  • Molecular Biology 1.5k
  • Hematology 1.1k
  • Oncology 794
  • Cancer Research 197
  • Pathology and Forensic Medicine 175
Replace Constantine Mitsiades with:
Constantine Mitsiades United States
D Chauhan India
Frederic J. Reu United States
Iris Breitkreutz United States
K. Martin Kortüm Germany
Elisabet E. Manasanch United States
Ichiro Hanamura Japan
Michaël Sébag Canada
Claire Seedhouse United Kingdom
G Schwab United States
K C Anderson relative to Constantine Mitsiades United States Constantine Mitsiades's profile →
Citations per field
00.5×1.5×
Constantine Mitsiades · 1×
Citations per year

Countries citing papers authored by K C Anderson

Since Specialization
Citations

This map shows the geographic impact of K C Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K C Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K C Anderson more than expected).

Fields of papers citing papers by K C Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K C Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K C Anderson. The network helps show where K C Anderson may publish in the future.

Co-authorship network of co-authors of K C Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of K C Anderson. A scholar is included among the top collaborators of K C Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K C Anderson. K C Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 53
2 4
3 71
4 46
5 26
6 100
7 63
8 37
9 114
10 65
11 62
12 16
13 30
14 2
15 5
16 23
17
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.breakdown →
1219
18 2
19 18
20
Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.
35

About K C Anderson

K C Anderson is a scholar working on Hematology, Oncology and Molecular Biology, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Protein Degradation and Inhibitors (8 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Hematology (1.1k citations), Oncology (794 citations) and Molecular Biology (1.5k citations). K C Anderson has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Paul G. Richardson, Teru Hideshima, D Chauhan, Julian Adams, Vito J. Palombella, Peter J. Elliott, Sagar Lonial, Nikhil C. Munshi, Nikhil Vad and James J. Driscoll. Their work appears in journals such as Journal of Clinical Oncology, Oncogene and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026